PBS Biotech, a leading provider of cell therapy manufacturing equipment and processes, secures its largest funding round to date to grow its product offerings and capabilities. CAMARILLO, Calif. — Single-use bioreactor manufacturer, PBS Biotech, recently closed a private $10M funding round with BroadOak Capital Partners. The financing will enable the company to expand and industrialize […]
SAN FRANCISCO — Marama Labs, a deep-tech sensor and data analytics company based in Wellington, New Zealand has received NZ$500,000 in funding from Quidnet Ventures, a New Zealand-based venture capital fund with operations in Auckland, NZ, San Francisco and New York.. Marama Labs has developed CloudSpec: the world’s first UV-Vis spectrophotometer that can simultaneously measure absorption, extinction, and scattering spectra of clear and turbid liquids. This […]
Oxford Biomedical Research, Inc. Awarded USDA Grant to Develop Tests for the Quality of Animal Feeds
ROCHESTER HILLS, Mich. — Oxford Biomedical Research, Inc., a privately held biotechnology company, has been awarded a $99,203 Phase I Small Business Innovation Research Grant by the National Institute of Food and Agriculture [NIFA, award #2021-33530-34397]. This grant, entitled “SIMPLE & RAPID TESTS FOR THE QUALITY OF ANIMAL FEEDS” will support the development of rapid tests to evaluate the […]
FREMONT, Calif. — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the pricing of its initial public offering of an aggregate of 16,749,330 shares of its common stock at a price to the public of $17.00 per share. The gross proceeds to Cytek from the offering, […]
BOSTON and LAUSANNE, Switzerland — SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today the pricing of its initial public offering of 13,000,000 ordinary shares at a price of $18 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions […]
TOKYO — OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has raised ¥800 million in Series B financing led by The University of Tokyo Edge Capital Partners (UTEC) with participation of ITOCHU Technology Ventures (ITV). OriCiro has also received a ¥200 million […]
Capital Partners to Expand Commercial Activities and Accelerate Product Development CHADDS FORD, Pa. — MOBILion Systems Inc., a pioneer in fast, efficient, highresolution instrumentation for biomarker discovery, diagnostics and biotherapeutic drug characterization, today announced the close of a $60 million Series C financing round. The round was led by D1 Capital Partners with the remaining funds contributed by existing investors […]
The winning technology will detect dangerous contents in drugs and help save lives Ottawa, ON | Health Canada The overdose crisis continues to affect communities and families across Canada. Tragically, Canada has experienced higher rates of overdoses since the onset of COVID-19, due in part to the increasing toxicity of the illegal drug supply. […]
Pleasanton, Calif.—Apton Biosystems, Inc., a developer of Super-Res sequencing and single-molecule detection systems for large-scale clinical applications, such as early cancer detection and population sequencing, today announced the close of a $24 million Series-A financing. The financing was led by Kern Capital with participation by new and existing investors including Casdin Capital and Khosla Ventures. […]
Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the close of a $276 million Series C financing. New investors Janus Henderson Investors, Logos Capital, Meritech Capital Partners, Counterpoint Global (Morgan Stanley), and T. Rowe Price joined existing investors Fidelity Management & Research Company, Foresite Capital, JS Capital Management LLC, RA Capital Advisors, and Venrock. With this latest investment, Element Biosciences […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
